Multifunctional Smart Yolk–Shell Nanostructure with Mesoporous MnO 2 Shell for Enhanced Cancer Therapy
Hongjun Zhuang,Mengyao Zhao,Shenglong Ding,Lingyan Liu,Wei Yuan,Liping Jiang,Xuemin Han,Libo Jiang,Tao Yi
DOI: https://doi.org/10.1021/acsami.0c08389
2020-08-11
Abstract:Manganese dioxide (MnO<sub>2</sub>) nanostructures have aroused great interest among analytical and biological medicine researchers as a unique type of tumor microenvironment (TME)-responsive nanomaterial. However, reliable approaches for synthesizing yolk–shell nanostructures (YSNs) with mesoporous MnO<sub>2</sub> shell still remain exciting challenges. Herein, a YSN (size, ∼75 nm) containing a mesoporous MnO<sub>2</sub> shell and Er<sup>3+</sup>-doped upconversion/downconversion nanoparticle (UCNP) core with a large cavity is demonstrated for the first time. This nanostructure not only integrates diverse functional components including MnO<sub>2</sub>, UCNPs, and YSNs into one system but also endows a size-controllable hollow cavity and thickness-tunable MnO<sub>2</sub> layers, which can load various guest molecules like photosensitizers, methylene blue (MB), and the anticancer drugs doxorubicin (DOX). NIR-II fluorescence and photoacoustic (PA) imaging from UCNP and MB, respectively, can monitor the enrichment of the nanomaterials in the tumors for guiding chemo-photodynamic therapy (PDT) <i>in vivo</i>. In the TME, degradation of the mMnO<sub>2</sub> shell by H<sub>2</sub>O<sub>2</sub> and GSH not only generates Mn<sup>2+</sup> for tumor-specific T<sub>1</sub>-MR imaging but also releases O<sub>2</sub> and drugs for tumor-specific treatment. The result confirmed that imaging-guided enhanced chemo-PDT combination therapy that benefited from the unique structural features of YSNs could substantially improve the therapeutic effectiveness toward malignant tumors compared to monotherapy.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c08389?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c08389</a>.Experimental details and characterization of nanomaterials; additional TEM, HRTEM, and SEM images and EDS spectra; additional upconversion emission spectra, UV–vis absorption spectra, zeta potentials, and N<sub>2</sub> absorption–desorption isotherm; additional relative viabilities, CLSM details, and images; and additional tumor photographs of the treated mice and body weight changes of different groups in the therapeutic period (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c08389/suppl_file/am0c08389_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
materials science, multidisciplinary,nanoscience & nanotechnology